Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach-Reference-Cited by-同舟云学术

Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach

Published:2023-08 Issue: Volume:164 Page:114918
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Saber Sameh^ORCID,Hasan Alexandru Madalin,Mohammed Osama A.,Saleh Lobna A.,Hashish Abdullah A.,Alamri Mohannad Mohammad S.,Al-Ameer Ahmed Y.,Alfaifi Jaber^ORCID,Senbel Ahmed^ORCID,Aboregela Adel Mohamed,Khalid Tarig Babikir Algak,Abdel-Reheim Mustafa Ahmed,Cavalu Simona^ORCID

Funder

University of Bisha

Shaqra University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference63 articles.

1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Prim.,2021

2. Hepatocellular Carcinoma;Villanueva;N. Engl. J. Med.,2019

3. E.E. Abd El-Fattah, S. Saber, M.E. Youssef, H. Eissa, E. El-Ahwany, N.A. Amin, M. Alqarni, G.E.-S. Batiha, A.J. Obaidullah, M.M.Y. Kaddah, A.G. Ahmed Gaafar, A.A.E. Mourad, G. Mostafa-Hedeab, A.M. Abdelhamid, AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma, 12 (2022).

4. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression;Saber;Biomed. Pharmacother.,2021

5. Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: emerging approach for new application;Abdelhamid;Biomed. Pharmacother.,2022

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib);Life Sciences;2024-10

2. STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide;Frontiers in Pharmacology;2024-09-04

3. Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects;Cell Death Discovery;2024-08-08

4. Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenib;Life Sciences;2024-08

5. The multifaceted role of beta‐blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders;The FASEB Journal;2024-07-08